Literature DB >> 12392853

Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells.

Raffaello Cortesini1, Elvira Renna-Molajoni, Paola Cinti, Renzo Pretagostini, Eric Ho, Paola Rossi, Nicole Suciu-Foca Cortesini.   

Abstract

Although transplantation tolerance cannot be yet reliably achieved in humans, there is evidence that active immunosuppression contributes to the maintenance of quiescence. However, the mechanism that underlies quiescence and the precise identity of regulatory cells are not completely understood. We have demonstrated that allograft recipients who remain rejection-free display allospecific T-suppressor cells (Ts). Ts express the CD8(+) CD28(-) phenotype, recognize major histocompatibility complex (MHC) class I antigens, and suppress the up-regulation of costimulatory molecules induced by CD40 ligation of donor antigen presenting cells. The presence of Ts is inversely correlated with T cell alloreactivity to donor MHC peptides, alloantibody production, and rejection. Monitoring of Ts has been successfully used in our studies for tailoring immunosuppression in kidney and liver allograft recipients.

Entities:  

Mesh:

Year:  2002        PMID: 12392853     DOI: 10.1016/s0198-8859(02)00442-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

1.  High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation.

Authors:  Peilun Cheng; Liming Zhong; Zesheng Jiang; Yan Wang; Mingxin Pan; Y I Gao
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

Review 2.  Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress.

Authors:  Rita B Effros
Journal:  Exp Gerontol       Date:  2010-09-15       Impact factor: 4.032

Review 3.  Clinical transplantation tolerance.

Authors:  Kenneth A Newell
Journal:  Semin Immunopathol       Date:  2011-02-14       Impact factor: 9.623

4.  Noninvasive methods to assess the risk of kidney transplant rejection.

Authors:  Paolo Cravedi; Roslyn B Mannon
Journal:  Expert Rev Clin Immunol       Date:  2009-09-01       Impact factor: 4.473

5.  Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.

Authors:  Steven R Fauce; Otto O Yang; Rita B Effros
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

6.  Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

Authors:  R A Nash; M Yunosov; K Abrams; B Hwang; C Castilla-Llorente; P Chen; A S Farivar; G E Georges; R C Hackman; W J E Lamm; M Lesnikova; H D Ochs; J Randolph-Habecker; S F Ziegler; R Storb; B Storer; D K Madtes; R Glenny; M S Mulligan
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

7.  Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.

Authors:  Sunjae Bae; Jacqueline M Garonzik-Wang; Allan B Massie; Mara A McAdams-DeMarco; Josef Coresh; Dorry L Segev
Journal:  Clin Transplant       Date:  2020-12-12       Impact factor: 2.863

Review 8.  A New Window into the Human Alloresponse.

Authors:  Susan DeWolf; Yufeng Shen; Megan Sykes
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

9.  Social and interpersonal relationship modifications after renal transplant. A statistic and epidemiologic evaluation.

Authors:  F Famà; E Micali; C Linard; M D Venuti; G Costantino; M Gioffrè-Florio
Journal:  J Prev Med Hyg       Date:  2013-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.